JP2025503649A5 - - Google Patents

Info

Publication number
JP2025503649A5
JP2025503649A5 JP2024541230A JP2024541230A JP2025503649A5 JP 2025503649 A5 JP2025503649 A5 JP 2025503649A5 JP 2024541230 A JP2024541230 A JP 2024541230A JP 2024541230 A JP2024541230 A JP 2024541230A JP 2025503649 A5 JP2025503649 A5 JP 2025503649A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
patient
approximately
antidepressant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024541230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025503649A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2023/050171 external-priority patent/WO2023131921A1/en
Publication of JP2025503649A publication Critical patent/JP2025503649A/ja
Publication of JP2025503649A5 publication Critical patent/JP2025503649A5/ja
Pending legal-status Critical Current

Links

JP2024541230A 2022-01-10 2023-01-09 うつ病の治療のための組成物及び方法 Pending JP2025503649A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263298060P 2022-01-10 2022-01-10
US63/298,060 2022-01-10
PCT/IB2023/050171 WO2023131921A1 (en) 2022-01-10 2023-01-09 Compositions and methods for the treatment of depression

Publications (2)

Publication Number Publication Date
JP2025503649A JP2025503649A (ja) 2025-02-04
JP2025503649A5 true JP2025503649A5 (https=) 2026-01-19

Family

ID=84981673

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541230A Pending JP2025503649A (ja) 2022-01-10 2023-01-09 うつ病の治療のための組成物及び方法

Country Status (10)

Country Link
US (1) US20250064779A1 (https=)
EP (1) EP4463143A1 (https=)
JP (1) JP2025503649A (https=)
KR (1) KR20240132501A (https=)
CN (1) CN118843459A (https=)
AU (1) AU2023206048A1 (https=)
CA (1) CA3247733A1 (https=)
IL (1) IL314176A (https=)
MX (1) MX2024008619A (https=)
WO (1) WO2023131921A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723133A1 (de) 1997-06-03 1998-12-10 Caideil M P Teoranta Tourmakea Austragvorrichtung für Medien
WO2009094260A1 (en) * 2008-01-22 2009-07-30 Eli Lilly And Company Kappa selective opioid receptor antagonist
JP2022548233A (ja) * 2019-09-13 2022-11-17 ヤンセン ファーマシューティカルズ,インコーポレーテッド エスケタミンの鼻腔内投与

Similar Documents

Publication Publication Date Title
US11793794B2 (en) Combination therapy for treating or preventing depression or other mood diseases
Huang et al. New treatment strategies of depression: based on mechanisms related to neuroplasticity
JP2020180141A5 (https=)
JP2015526458A5 (https=)
Block et al. Emerging antidepressants to treat major depressive disorder
JP2016506933A5 (https=)
BG108379A (bg) Използване на енантиомерно чист есциталопрам
CN107823195A (zh) R‑氯胺酮在抑郁症急性期治疗中的应用
KR20070083826A (ko) 우울증을 위한 부가 요법
CN114727989A (zh) Gaba-a受体正变构调节剂与nmda拮抗剂、nmda负变构调节剂或nmda部分激动剂的组合
RU2020125170A (ru) Композиции и способы улучшения биодоступности 5-гидрокситриптофана
KR20060032598A (ko) 세로토닌 재흡수 억제제 및 아고멜라틴의 조합
JP2022546456A5 (https=)
JP2023549849A5 (https=)
JP2025502098A5 (https=)
JP2025503649A5 (https=)
CN105848655B (zh) 用于注意力和认知障碍的、以及用于与神经变性障碍相关联的痴呆的新疗法
JP2025503646A5 (https=)
RU2024122072A (ru) Композиции и способы лечения депрессии
Stahl Combining antidepressant therapies from the initiation of treatment: a paradigm shift for major depression
MD3700514T2 (ro) Combinație de inhibitori ai IL-8 și inhibitori ai IL-6/GP-130 pentru utilizare în tratamentul metastazelor pulmonare asociate cu osteosarcomul
JP2023509484A5 (https=)
CA3100635A1 (en) Combinations comprising tropifexor and cenicriviroc
Orfanos et al. Treprostinil, an EP-2 Agonist, Decreases Lung Fibroblasts Extra-Cellular Matrix Production in a cAMP Dependent Manner
JP2024529022A5 (https=)